Myasthenic patients' IgG causes redistribution of acetylcholine receptors: Freeze-fracture studies

D. W. Pumplin, Daniel B Drachman

Research output: Contribution to journalArticle

Abstract

Immunoglobulin from patients with myasthenia gravis (MG) accelerates the degradation of acetylcholine receptors (AChRs) of skeletal muscle by a mechanism dependent on receptor crosslinking. However, the intermediate steps between cross-linking and endocytosis and degradation are not known. We have used freeze-fracture electron microscopy to study the effects of myasthenic immunoglobulin on the distribution of AChRs in the surface membranes of cultured rat skeletal muscle. Large, angular intramembrane particles were identified as AChRs. These particles were present in three configurations: distributed individually; in 'hot spots'; and in clusters of two to 60 particles. Large depressions (> 100 nm in diameter) were thought to be endocytotic pits; they occurred preferentially in hot spots, and approximately half of the depressions were closely associated with clusters of AChRs. In control myotubes, hot spots contained a high density of AChR particles that were evenly, rather than randomly, distributed. Exposure to myasthenic patients' IgG induced clustering of the particles within such hot spots. In non-hot spot regions, control myotubes had mainly individually distributed AChRs, while clusters were seen only rarely. The addition of myasthenic IgG caused a rapid increase, followed by a gradual decrease, in the incidence of individual clusters as well as an increase in cluster size. This redistribution of particles was dependent on cross-linking by the myasthenic anti-AChR antibodies. Monovalent Fab fragments of myasthenic IgG had no effect on the distribution of AChR particles. However, addition of a second 'piggyback' antibody to cross-link Fab-AChR complexes caused a redistribution of AChR particles like that due to the original myasthenic IgG. These findings indicate that cross-linking of AChRs by divalent antibody causes clustering of AChR particles, which may play an important role in their accelerated endocytosis and degradation.

Original languageEnglish (US)
Pages (from-to)576-584
Number of pages9
JournalJournal of Neuroscience
Volume3
Issue number3
StatePublished - 1983
Externally publishedYes

Fingerprint

Muscle Weakness
Cholinergic Receptors
Immunoglobulin G
Skeletal Muscle Fibers
Endocytosis
Cluster Analysis
Antibodies
Immunoglobulins
Skeletal Muscle
Immunoglobulin Fab Fragments
Myasthenia Gravis
Electron Microscopy

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Myasthenic patients' IgG causes redistribution of acetylcholine receptors : Freeze-fracture studies. / Pumplin, D. W.; Drachman, Daniel B.

In: Journal of Neuroscience, Vol. 3, No. 3, 1983, p. 576-584.

Research output: Contribution to journalArticle

@article{78ddc7f83390476b9b2567ecbe01828a,
title = "Myasthenic patients' IgG causes redistribution of acetylcholine receptors: Freeze-fracture studies",
abstract = "Immunoglobulin from patients with myasthenia gravis (MG) accelerates the degradation of acetylcholine receptors (AChRs) of skeletal muscle by a mechanism dependent on receptor crosslinking. However, the intermediate steps between cross-linking and endocytosis and degradation are not known. We have used freeze-fracture electron microscopy to study the effects of myasthenic immunoglobulin on the distribution of AChRs in the surface membranes of cultured rat skeletal muscle. Large, angular intramembrane particles were identified as AChRs. These particles were present in three configurations: distributed individually; in 'hot spots'; and in clusters of two to 60 particles. Large depressions (> 100 nm in diameter) were thought to be endocytotic pits; they occurred preferentially in hot spots, and approximately half of the depressions were closely associated with clusters of AChRs. In control myotubes, hot spots contained a high density of AChR particles that were evenly, rather than randomly, distributed. Exposure to myasthenic patients' IgG induced clustering of the particles within such hot spots. In non-hot spot regions, control myotubes had mainly individually distributed AChRs, while clusters were seen only rarely. The addition of myasthenic IgG caused a rapid increase, followed by a gradual decrease, in the incidence of individual clusters as well as an increase in cluster size. This redistribution of particles was dependent on cross-linking by the myasthenic anti-AChR antibodies. Monovalent Fab fragments of myasthenic IgG had no effect on the distribution of AChR particles. However, addition of a second 'piggyback' antibody to cross-link Fab-AChR complexes caused a redistribution of AChR particles like that due to the original myasthenic IgG. These findings indicate that cross-linking of AChRs by divalent antibody causes clustering of AChR particles, which may play an important role in their accelerated endocytosis and degradation.",
author = "Pumplin, {D. W.} and Drachman, {Daniel B}",
year = "1983",
language = "English (US)",
volume = "3",
pages = "576--584",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "3",

}

TY - JOUR

T1 - Myasthenic patients' IgG causes redistribution of acetylcholine receptors

T2 - Freeze-fracture studies

AU - Pumplin, D. W.

AU - Drachman, Daniel B

PY - 1983

Y1 - 1983

N2 - Immunoglobulin from patients with myasthenia gravis (MG) accelerates the degradation of acetylcholine receptors (AChRs) of skeletal muscle by a mechanism dependent on receptor crosslinking. However, the intermediate steps between cross-linking and endocytosis and degradation are not known. We have used freeze-fracture electron microscopy to study the effects of myasthenic immunoglobulin on the distribution of AChRs in the surface membranes of cultured rat skeletal muscle. Large, angular intramembrane particles were identified as AChRs. These particles were present in three configurations: distributed individually; in 'hot spots'; and in clusters of two to 60 particles. Large depressions (> 100 nm in diameter) were thought to be endocytotic pits; they occurred preferentially in hot spots, and approximately half of the depressions were closely associated with clusters of AChRs. In control myotubes, hot spots contained a high density of AChR particles that were evenly, rather than randomly, distributed. Exposure to myasthenic patients' IgG induced clustering of the particles within such hot spots. In non-hot spot regions, control myotubes had mainly individually distributed AChRs, while clusters were seen only rarely. The addition of myasthenic IgG caused a rapid increase, followed by a gradual decrease, in the incidence of individual clusters as well as an increase in cluster size. This redistribution of particles was dependent on cross-linking by the myasthenic anti-AChR antibodies. Monovalent Fab fragments of myasthenic IgG had no effect on the distribution of AChR particles. However, addition of a second 'piggyback' antibody to cross-link Fab-AChR complexes caused a redistribution of AChR particles like that due to the original myasthenic IgG. These findings indicate that cross-linking of AChRs by divalent antibody causes clustering of AChR particles, which may play an important role in their accelerated endocytosis and degradation.

AB - Immunoglobulin from patients with myasthenia gravis (MG) accelerates the degradation of acetylcholine receptors (AChRs) of skeletal muscle by a mechanism dependent on receptor crosslinking. However, the intermediate steps between cross-linking and endocytosis and degradation are not known. We have used freeze-fracture electron microscopy to study the effects of myasthenic immunoglobulin on the distribution of AChRs in the surface membranes of cultured rat skeletal muscle. Large, angular intramembrane particles were identified as AChRs. These particles were present in three configurations: distributed individually; in 'hot spots'; and in clusters of two to 60 particles. Large depressions (> 100 nm in diameter) were thought to be endocytotic pits; they occurred preferentially in hot spots, and approximately half of the depressions were closely associated with clusters of AChRs. In control myotubes, hot spots contained a high density of AChR particles that were evenly, rather than randomly, distributed. Exposure to myasthenic patients' IgG induced clustering of the particles within such hot spots. In non-hot spot regions, control myotubes had mainly individually distributed AChRs, while clusters were seen only rarely. The addition of myasthenic IgG caused a rapid increase, followed by a gradual decrease, in the incidence of individual clusters as well as an increase in cluster size. This redistribution of particles was dependent on cross-linking by the myasthenic anti-AChR antibodies. Monovalent Fab fragments of myasthenic IgG had no effect on the distribution of AChR particles. However, addition of a second 'piggyback' antibody to cross-link Fab-AChR complexes caused a redistribution of AChR particles like that due to the original myasthenic IgG. These findings indicate that cross-linking of AChRs by divalent antibody causes clustering of AChR particles, which may play an important role in their accelerated endocytosis and degradation.

UR - http://www.scopus.com/inward/record.url?scp=0020534736&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020534736&partnerID=8YFLogxK

M3 - Article

C2 - 6827310

AN - SCOPUS:0020534736

VL - 3

SP - 576

EP - 584

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 3

ER -